메뉴 건너뛰기




Volumn 34, Issue 35, 2013, Pages 8941-8948

Mn2+-doped silica nanoparticles for hepatocyte-targeted detection of liver cancer in T1-weighted MRI

Author keywords

Contrast agent; Liver; Manganese; MRI (magnetic resonance imaging); Nanoparticle; Silica

Indexed keywords

CONTRAST AGENT; CONTRAST ENHANCEMENT; CONTRAST-ENHANCED; HUMAN HEPATOCELLULAR CARCINOMA (HCC); MR CONTRAST AGENTS; MRI (MAGNETIC RESONANCE IMAGING); MRI CONTRAST AGENTS; PARENCHYMA TISSUES;

EID: 84883223901     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.08.009     Document Type: Article
Times cited : (57)

References (42)
  • 1
    • 77952484017 scopus 로고    scopus 로고
    • Challenges for molecular magnetic resonance imaging
    • Terreno E., Castelli D.D., Viale A., Aime S. Challenges for molecular magnetic resonance imaging. Chem Rev 2010, 110:3019-3042.
    • (2010) Chem Rev , vol.110 , pp. 3019-3042
    • Terreno, E.1    Castelli, D.D.2    Viale, A.3    Aime, S.4
  • 2
    • 77952537647 scopus 로고    scopus 로고
    • Multimodality imaging probes: design and challenges
    • Louie A. Multimodality imaging probes: design and challenges. Chem Rev 2010, 110:3146-3195.
    • (2010) Chem Rev , vol.110 , pp. 3146-3195
    • Louie, A.1
  • 3
    • 37349014497 scopus 로고    scopus 로고
    • Use of contrast agents for liver MRI
    • Ward J. Use of contrast agents for liver MRI. Radiography 2007, 13:e54-72.
    • (2007) Radiography , vol.13
    • Ward, J.1
  • 6
    • 84871659077 scopus 로고    scopus 로고
    • Gadolinium-based contrast agents for magnetic resonancecancer imaging
    • Zhou Z., Lu Z.-R. Gadolinium-based contrast agents for magnetic resonancecancer imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2013, 5:1-18.
    • (2013) Wiley Interdiscip Rev Nanomed Nanobiotechnol , vol.5 , pp. 1-18
    • Zhou, Z.1    Lu, Z.-R.2
  • 7
    • 34548524200 scopus 로고    scopus 로고
    • Small molecular gadolinium(III) complexes as MRI contrast agents for diagnostic imaging
    • Chan K.W.-Y., Wong W.-T. Small molecular gadolinium(III) complexes as MRI contrast agents for diagnostic imaging. Coord Chem Rev 2007, 251:2428-2451.
    • (2007) Coord Chem Rev , vol.251 , pp. 2428-2451
    • Chan, K.W.-Y.1    Wong, W.-T.2
  • 8
    • 0346270559 scopus 로고    scopus 로고
    • Currently used non-specific extracellular MR contrast media
    • Bellin M.F., Vasile M., Morel-Precetti S. Currently used non-specific extracellular MR contrast media. Eur Radiol 2003, 13:2688-2698.
    • (2003) Eur Radiol , vol.13 , pp. 2688-2698
    • Bellin, M.F.1    Vasile, M.2    Morel-Precetti, S.3
  • 9
    • 43049114497 scopus 로고    scopus 로고
    • Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting
    • Broome D.R. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting. Eur J Radiol 2008, 66:230-234.
    • (2008) Eur J Radiol , vol.66 , pp. 230-234
    • Broome, D.R.1
  • 10
    • 33847239121 scopus 로고    scopus 로고
    • Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis
    • Kuo P.H., Kanal E., Abu-Alfa A.K., Cowper S.E. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 2007, 242:647-649.
    • (2007) Radiology , vol.242 , pp. 647-649
    • Kuo, P.H.1    Kanal, E.2    Abu-Alfa, A.K.3    Cowper, S.E.4
  • 11
    • 79958776497 scopus 로고    scopus 로고
    • Synthesis and bio-functionalization of magnetic nanoparticles for medical diagnosis and treatment
    • Schladt T.D., Schneider K., Schild H., Tremel W. Synthesis and bio-functionalization of magnetic nanoparticles for medical diagnosis and treatment. Dalton Trans 2011, 40:6315-6343.
    • (2011) Dalton Trans , vol.40 , pp. 6315-6343
    • Schladt, T.D.1    Schneider, K.2    Schild, H.3    Tremel, W.4
  • 12
    • 67649264901 scopus 로고    scopus 로고
    • Inorganic nanoparticles for MRI contrast agents
    • Na H.B., Song I.C., Hyeon T. Inorganic nanoparticles for MRI contrast agents. Adv Mater 2009, 21:2133-2148.
    • (2009) Adv Mater , vol.21 , pp. 2133-2148
    • Na, H.B.1    Song, I.C.2    Hyeon, T.3
  • 13
    • 47249140441 scopus 로고    scopus 로고
    • Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications
    • Laurent S., Forge D., Port M., Roch A., Robic C., Elst L.V., et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008, 108:2064-2110.
    • (2008) Chem Rev , vol.108 , pp. 2064-2110
    • Laurent, S.1    Forge, D.2    Port, M.3    Roch, A.4    Robic, C.5    Elst, L.V.6
  • 14
    • 33646115661 scopus 로고    scopus 로고
    • Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma
    • Tanimoto A., Kuribayashi S. Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma. Eur J Radiol 2006, 58:200-216.
    • (2006) Eur J Radiol , vol.58 , pp. 200-216
    • Tanimoto, A.1    Kuribayashi, S.2
  • 15
    • 33751410697 scopus 로고    scopus 로고
    • Recent advances in iron oxide nanocrystal technology for medical imaging
    • Corot C., Robert P., Idée J.-M., Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 2006, 58:1471-1504.
    • (2006) Adv Drug Deliv Rev , vol.58 , pp. 1471-1504
    • Corot, C.1    Robert, P.2    Idée, J.-M.3    Port, M.4
  • 16
    • 78650743445 scopus 로고    scopus 로고
    • Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles
    • Huang J., Bu L., Xie J., Chen K., Cheng Z., Li X., et al. Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles. ACS Nano 2010, 4:7151-7160.
    • (2010) ACS Nano , vol.4 , pp. 7151-7160
    • Huang, J.1    Bu, L.2    Xie, J.3    Chen, K.4    Cheng, Z.5    Li, X.6
  • 17
    • 0023801420 scopus 로고
    • Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver
    • Stark D.D., Weissleder R., Elizondo G., Hahn P.F., Saini S., Todd L.E., et al. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 1988, 168:297-301.
    • (1988) Radiology , vol.168 , pp. 297-301
    • Stark, D.D.1    Weissleder, R.2    Elizondo, G.3    Hahn, P.F.4    Saini, S.5    Todd, L.E.6
  • 18
    • 0028020159 scopus 로고
    • Liver MR imaging with iron oxides: toward consensus and clinical practice
    • Weissleder R. Liver MR imaging with iron oxides: toward consensus and clinical practice. Radiology 1994, 193:593-595.
    • (1994) Radiology , vol.193 , pp. 593-595
    • Weissleder, R.1
  • 19
    • 84859899426 scopus 로고    scopus 로고
    • Manganese(II) complexes as potential contrast agents for MRI
    • Drahoš B., Lukeš I., Tóth É. Manganese(II) complexes as potential contrast agents for MRI. Eur J Inorg Chem 2012, 1975-1986.
    • (2012) Eur J Inorg Chem , pp. 1975-1986
    • Drahoš, B.1    Lukeš, I.2    Tóth, É.3
  • 20
    • 84859884307 scopus 로고    scopus 로고
    • Manganese-enhanced MRI contrast agents: from small chelates to nanosized hybrids
    • Kueny-Stotz M., Garofalo A., Felder-Flesch D. Manganese-enhanced MRI contrast agents: from small chelates to nanosized hybrids. Eur J Inorg Chem 2012, 1987-2005.
    • (2012) Eur J Inorg Chem , pp. 1987-2005
    • Kueny-Stotz, M.1    Garofalo, A.2    Felder-Flesch, D.3
  • 21
    • 80053278341 scopus 로고    scopus 로고
    • Manganese-based MRI contrast agents: past, present, and future
    • Pan D., Schmieder A.H., Wickline S.A., Lanza G.M. Manganese-based MRI contrast agents: past, present, and future. Tetrahedron 2011, 67:8431-8444.
    • (2011) Tetrahedron , vol.67 , pp. 8431-8444
    • Pan, D.1    Schmieder, A.H.2    Wickline, S.A.3    Lanza, G.M.4
  • 22
    • 77449106886 scopus 로고    scopus 로고
    • Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree
    • Seal M.K., Catalano O.A., Saini S., Hahn P.F., Sahani D.V. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics 2009, 29:1725-1748.
    • (2009) Radiographics , vol.29 , pp. 1725-1748
    • Seal, M.K.1    Catalano, O.A.2    Saini, S.3    Hahn, P.F.4    Sahani, D.V.5
  • 26
    • 82855179425 scopus 로고    scopus 로고
    • Manganese based MR contrast agents: formulation and clinical applications
    • Chabanova E., Logager V.B., Moller J.M., Thomsen H.S. Manganese based MR contrast agents: formulation and clinical applications. Open Drug Saf J 2011, 2:29-38.
    • (2011) Open Drug Saf J , vol.2 , pp. 29-38
    • Chabanova, E.1    Logager, V.B.2    Moller, J.M.3    Thomsen, H.S.4
  • 29
    • 33746211280 scopus 로고    scopus 로고
    • Invitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility
    • Brunner T.J., Wick P., Manser P., Spohn P., Grass R.N., Limbach L.K., et al. Invitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ Sci Technol 2006, 40:4374-4381.
    • (2006) Environ Sci Technol , vol.40 , pp. 4374-4381
    • Brunner, T.J.1    Wick, P.2    Manser, P.3    Spohn, P.4    Grass, R.N.5    Limbach, L.K.6
  • 30
    • 84864290990 scopus 로고    scopus 로고
    • Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells
    • Chen Y., Yin Q., Ji X., Zhang S., Chen H., Zheng Y., et al. Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells. Biomaterials 2012, 33:7126-7137.
    • (2012) Biomaterials , vol.33 , pp. 7126-7137
    • Chen, Y.1    Yin, Q.2    Ji, X.3    Zhang, S.4    Chen, H.5    Zheng, Y.6
  • 32
    • 58249114007 scopus 로고    scopus 로고
    • Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery
    • Shin J., Anisur R.M., Ko M.K., Im G.H., Lee J.H., Lee I.S. Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery. Angew Chem Int Ed 2009, 48:321-324.
    • (2009) Angew Chem Int Ed , vol.48 , pp. 321-324
    • Shin, J.1    Anisur, R.M.2    Ko, M.K.3    Im, G.H.4    Lee, J.H.5    Lee, I.S.6
  • 33
    • 55549086881 scopus 로고    scopus 로고
    • Manganese-based nanoscale metal-organic frameworks for magnetic resonance imaging
    • Taylor K.M.L., Rieter W.J., Lin W. Manganese-based nanoscale metal-organic frameworks for magnetic resonance imaging. JAm Chem Soc 2008, 130:14358-14359.
    • (2008) JAm Chem Soc , vol.130 , pp. 14358-14359
    • Taylor, K.M.L.1    Rieter, W.J.2    Lin, W.3
  • 34
    • 49049096312 scopus 로고    scopus 로고
    • Convertible manganese contrast for molecular and cellular MRI
    • Shapiro E.M., Koretsky A.P. Convertible manganese contrast for molecular and cellular MRI. Magn Reson Med 2008, 60:265-269.
    • (2008) Magn Reson Med , vol.60 , pp. 265-269
    • Shapiro, E.M.1    Koretsky, A.P.2
  • 36
    • 80051496142 scopus 로고    scopus 로고
    • Biocompatible and pH-sensitive PLGA encapsulated MnO nanocrystals for molecular and cellular MRI
    • Bennewitz M.F., Lobo T.L., Nkansah M.K., Ulas G., Brudvig G.W., Shapiro E.M. Biocompatible and pH-sensitive PLGA encapsulated MnO nanocrystals for molecular and cellular MRI. ACS Nano 2011, 5:3438-3446.
    • (2011) ACS Nano , vol.5 , pp. 3438-3446
    • Bennewitz, M.F.1    Lobo, T.L.2    Nkansah, M.K.3    Ulas, G.4    Brudvig, G.W.5    Shapiro, E.M.6
  • 39
    • 77952722303 scopus 로고    scopus 로고
    • Hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging-correlation with expression of sinusoidal and canalicular transporters and bile accumulation
    • Tsuboyama T., Onishi H., Kim T., Akita H., Hori M., Tatsumi M., et al. Hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging-correlation with expression of sinusoidal and canalicular transporters and bile accumulation. Radiology 2010, 255:824-833.
    • (2010) Radiology , vol.255 , pp. 824-833
    • Tsuboyama, T.1    Onishi, H.2    Kim, T.3    Akita, H.4    Hori, M.5    Tatsumi, M.6
  • 40
    • 84866729700 scopus 로고    scopus 로고
    • Invivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics
    • Yu T., Hubbard D., Ray A., Ghandehari H. Invivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics. JControl Release 2012, 163:46-54.
    • (2012) JControl Release , vol.163 , pp. 46-54
    • Yu, T.1    Hubbard, D.2    Ray, A.3    Ghandehari, H.4
  • 41
    • 78651342869 scopus 로고    scopus 로고
    • Invivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation
    • He Q., Zhang Z., Gao F., Li Y., Shi J. Invivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation. Small 2011, 7:271-280.
    • (2011) Small , vol.7 , pp. 271-280
    • He, Q.1    Zhang, Z.2    Gao, F.3    Li, Y.4    Shi, J.5
  • 42
    • 79961071789 scopus 로고    scopus 로고
    • The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility invivo
    • Huang X., Li L., Liu T., Hao N., Liu H., Chen D., et al. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility invivo. ACS Nano 2011, 5:5390-5399.
    • (2011) ACS Nano , vol.5 , pp. 5390-5399
    • Huang, X.1    Li, L.2    Liu, T.3    Hao, N.4    Liu, H.5    Chen, D.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.